ReviewCancer drug resistance (Alhambra, Calif.)2019

Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins.

Clélia Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.